{"hands_on_practices": [{"introduction": "Before a biomarker can be used in clinical studies, its fundamental analytical performance must be rigorously characterized. Key to this is establishing the limits of reliable measurement: the Limit of Detection (LOD) and the Limit of Quantitation (LOQ). This practice challenges you to derive these critical parameters from first principles, connecting the statistical concepts of Type I and Type II errors to the practical task of assay validation [@problem_id:4525798].", "problem": "You are validating a quantitative assay for a candidate plasma biomarker in a clinical pharmacology study. Let the measured signal be modeled as a linear calibration with homoscedastic Gaussian noise: for true concentration $c$ (in ng/mL), the signal $S$ satisfies $S = a + b\\,c + \\varepsilon$, where $\\varepsilon \\sim \\mathcal{N}(0,\\sigma^{2})$, and $a$ equals the mean blank signal. The goals are to (i) define from first principles and derive the expressions for the limit of detection (LOD) and limit of quantitation (LOQ) on the concentration scale, and (ii) estimate them from blank and low-concentration replicates under Gaussian assumptions.\n\nAvailable data:\n- Blank replicates ($n = 10$) signals: $0.06, 0.12, 0.11, 0.19, 0.13, 0.08, 0.18, 0.15, 0.10, 0.14$ (arbitrary signal units).\n- Spiked replicates at known concentration $c_{L} = 1.00$ ng/mL ($n = 10$) signals: $0.88, 0.95, 0.90, 0.98, 0.93, 0.92, 0.96, 0.91, 0.89, 0.94$.\n- Type I error and Type II error targets for detection are $\\alpha = 0.05$ and $\\beta = 0.05$. Assume one-sided error control and use the standard normal quantile $z_{0.95} = 1.645$.\n- Define the limit of quantitation (LOQ) as the smallest concentration $c$ such that the coefficient of variation (CV) of the inverse-calibrated concentration estimator does not exceed $\\delta = 0.20$.\n\nTasks:\n- Starting from the Gaussian model and the definitions of Type I error and Type II error, derive the LOD on the concentration scale.\n- Starting from the Gaussian model and the definition of CV for the inverse-calibrated concentration estimate, derive the LOQ on the concentration scale.\n- Estimate $a$, $b$, and $\\sigma$ from the provided replicates using the sample mean and sample standard deviation for the blank, and the difference in means between the spiked and blank divided by $c_{L}$ for the slope.\n- Compute the numerical values of LOD and LOQ in ng/mL using your derived formulas.\n\nRound your final numerical answers to four significant figures. Express the final results in ng/mL. Report the ordered pair as $\\big(\\text{LOD}, \\text{LOQ}\\big)$.", "solution": "The problem statement has been validated and is deemed valid. It is scientifically grounded, well-posed, and objective. It presents a standard problem in analytical chemistry and clinical pharmacology concerning the validation of a quantitative assay. All necessary data, definitions, and constraints are provided to derive and compute the requested quantities.\n\nThe solution proceeds in three stages: first, estimation of the model parameters from the provided data; second, derivation of the expression for the Limit of Detection (LOD) and its numerical calculation; and third, derivation of the expression for the Limit of Quantitation (LOQ) and its numerical calculation.\n\n### 1. Estimation of Model Parameters\n\nThe analysis is based on the linear calibration model $S = a + bc + \\varepsilon$, where $S$ is the measured signal for a true concentration $c$, $a$ is the mean blank signal, $b$ is the sensitivity (slope), and $\\varepsilon$ is a homoscedastic Gaussian noise term with mean $0$ and variance $\\sigma^2$, i.e., $\\varepsilon \\sim \\mathcal{N}(0,\\sigma^{2})$.\n\n**Estimation of $a$ (mean blank signal):**\nThe parameter $a$ is estimated as the sample mean of the blank replicate signals. Let $S_{B,i}$ be the signal of the $i$-th blank replicate, with $n_B=10$.\nThe data are: $\\{0.06, 0.12, 0.11, 0.19, 0.13, 0.08, 0.18, 0.15, 0.10, 0.14\\}$.\nThe estimate $\\hat{a}$ is calculated as:\n$$\n\\hat{a} = \\bar{S}_B = \\frac{1}{n_B}\\sum_{i=1}^{n_B} S_{B,i} = \\frac{1.26}{10} = 0.126\n$$\n\n**Estimation of $\\sigma$ (noise standard deviation):**\nThe parameter $\\sigma$ is estimated from the standard deviation of the blank replicates, as this represents the noise floor of the assay, which is critical for determining detection and quantitation limits.\nThe sample variance of the blank signals is:\n$$\ns_B^2 = \\frac{1}{n_B-1}\\sum_{i=1}^{n_B} (S_{B,i} - \\bar{S}_B)^2 = \\frac{0.01524}{10-1} \\approx 0.0016933\n$$\nThe estimate $\\hat{\\sigma}$ is the sample standard deviation:\n$$\n\\hat{\\sigma} = s_B = \\sqrt{0.0016933} \\approx 0.0411501\n$$\n\n**Estimation of $b$ (slope/sensitivity):**\nThe parameter $b$ is estimated using the difference in mean signals between the spiked and blank replicates, divided by the known concentration of the spike, $c_L=1.00$ ng/mL.\nThe spiked replicate signals ($n_S=10$) are: $\\{0.88, 0.95, 0.90, 0.98, 0.93, 0.92, 0.96, 0.91, 0.89, 0.94\\}$.\nThe sample mean of the spiked signals, $\\bar{S}_S$, is:\n$$\n\\bar{S}_S = \\frac{1}{n_S}\\sum_{i=1}^{n_S} S_{S,i} = \\frac{9.26}{10} = 0.926\n$$\nThe estimate $\\hat{b}$ is then:\n$$\n\\hat{b} = \\frac{\\bar{S}_S - \\bar{S}_B}{c_L} = \\frac{0.926 - 0.126}{1.00} = 0.800\n$$\n\n### 2. Derivation and Calculation of LOD\n\nThe LOD is defined based on a hypothesis testing framework.\nThe null hypothesis, $H_0$, states that the sample is a blank ($c=0$), so its signal $S$ is drawn from $\\mathcal{N}(a, \\sigma^2)$.\nThe alternative hypothesis, $H_1$, states that the sample contains analyte at concentration $c>0$, so its signal $S$ is drawn from $\\mathcal{N}(a+bc, \\sigma^2)$.\n\nA decision is made based on a critical signal level, $S_{crit}$. If a measurement is greater than $S_{crit}$, $H_0$ is rejected.\n\nThe Type I error rate, $\\alpha=0.05$, is the probability of a false positive (rejecting $H_0$ when it is true):\n$$\n\\alpha = P(S > S_{crit} | c=0) = P\\left(\\frac{S-a}{\\sigma} > \\frac{S_{crit}-a}{\\sigma}\\right)\n$$\nFor a standard normal variable $Z$, this implies $\\frac{S_{crit}-a}{\\sigma} = z_{1-\\alpha}$, where $z_{1-\\alpha}$ is the $(1-\\alpha)$-quantile of the standard normal distribution. This gives the expression for the critical signal:\n$$\nS_{crit} = a + z_{1-\\alpha}\\sigma\n$$\nThe Type II error rate, $\\beta=0.05$, is the probability of a false negative (failing to reject $H_0$ when it is false). The LOD is the specific concentration $c=\\text{LOD}$ at which this error rate occurs:\n$$\n\\beta = P(S \\le S_{crit} | c=\\text{LOD}) = P\\left(\\frac{S - (a+b\\cdot\\text{LOD})}{\\sigma} \\le \\frac{S_{crit} - (a+b\\cdot\\text{LOD})}{\\sigma}\\right)\n$$\nThis implies $\\frac{S_{crit} - a - b\\cdot\\text{LOD}}{\\sigma} = z_{\\beta} = -z_{1-\\beta}$.\n\nSubstituting the expression for $S_{crit}-a$:\n$$\nz_{1-\\alpha}\\sigma - b\\cdot\\text{LOD} = -z_{1-\\beta}\\sigma\n$$\nSolving for LOD:\n$$\nb\\cdot\\text{LOD} = (z_{1-\\alpha} + z_{1-\\beta})\\sigma \\implies \\text{LOD} = \\frac{(z_{1-\\alpha} + z_{1-\\beta})\\sigma}{b}\n$$\nGiven $\\alpha = 0.05$ and $\\beta = 0.05$, we have $z_{1-\\alpha} = z_{1-\\beta} = z_{0.95} = 1.645$.\nSubstituting the estimated parameters:\n$$\n\\text{LOD} = \\frac{(1.645 + 1.645)\\hat{\\sigma}}{\\hat{b}} = \\frac{3.29 \\times 0.0411501}{0.800} \\approx 0.16922995\n$$\nRounding to four significant figures, the LOD is $0.1692$ ng/mL.\n\n### 3. Derivation and Calculation of LOQ\n\nThe LOQ is defined as the smallest concentration for which the coefficient of variation (CV) of the inverse-calibrated concentration estimate does not exceed a threshold $\\delta = 0.20$.\n\nThe concentration estimator, $\\hat{c}$, is obtained by inverting the calibration model for a measured signal $S$:\n$$\n\\hat{c} = \\frac{S - a}{b}\n$$\nAssuming the parameters $a$ and $b$ are known from a well-established calibration, the uncertainty in $\\hat{c}$ for a single measurement arises from the noise term $\\varepsilon$. The true concentration is $c$.\nThe expected value of the estimator is:\n$$\nE[\\hat{c}] = E\\left[\\frac{(a+bc+\\varepsilon)-a}{b}\\right] = E\\left[c + \\frac{\\varepsilon}{b}\\right] = c\n$$\nThe variance of the estimator is:\n$$\n\\text{Var}(\\hat{c}) = \\text{Var}\\left(c + \\frac{\\varepsilon}{b}\\right) = \\frac{1}{b^2}\\text{Var}(\\varepsilon) = \\frac{\\sigma^2}{b^2}\n$$\nThe standard deviation of the estimator is thus $\\text{SD}(\\hat{c}) = \\sigma/b$.\nThe coefficient of variation, CV, is the standard deviation divided by the mean (the true concentration $c$):\n$$\n\\text{CV}(\\hat{c}) = \\frac{\\text{SD}(\\hat{c})}{c} = \\frac{\\sigma/b}{c}\n$$\nThe LOQ is the concentration $c$ at which this CV equals the target $\\delta$:\n$$\n\\delta = \\frac{\\sigma/b}{\\text{LOQ}}\n$$\nSolving for LOQ:\n$$\n\\text{LOQ} = \\frac{\\sigma}{b\\delta}\n$$\nSubstituting the estimated parameters and the given value of $\\delta=0.20$:\n$$\n\\text{LOQ} = \\frac{\\hat{\\sigma}}{\\hat{b}\\delta} = \\frac{0.0411501}{0.800 \\times 0.20} = \\frac{0.0411501}{0.160} \\approx 0.257188\n$$\nRounding to four significant figures, the LOQ is $0.2572$ ng/mL.\nThe final ordered pair $(\\text{LOD}, \\text{LOQ})$ is $(0.1692, 0.2572)$ ng/mL.", "answer": "$$\n\\boxed{\n\\begin{pmatrix}\n0.1692 & 0.2572\n\\end{pmatrix}\n}\n$$", "id": "4525798"}, {"introduction": "A measured biomarker value is a composite signal reflecting not only analytical noise but also true biological variation. To properly interpret biomarker data, we must dissect the total observed variability into its core components: analytical, within-subject, and between-subject variance. This exercise guides you through estimating these variance components from a nested study design, a foundational skill for understanding a biomarker's behavior in a population [@problem_id:4525758].", "problem": "A translational clinical pharmacology team is evaluating the variability sources of a new plasma protein biomarker intended for enrichment of responders in a phase $2$ trial. To characterize the analytical, within-subject biological, and between-subject components of variability, they conducted a balanced hierarchical study in healthy volunteers. In this study, $n_S$ subjects were each sampled at $n_W$ distinct visits, and for each sample, $n_A$ independent analytical replicates were run on the assay. Let the observed replicate measurement be modeled as\n\n$$\ny_{ijk} = \\mu + S_i + W_{ij} + A_{ijk},\n$$\n\nwith $i = 1,\\dots,n_S$, $j = 1,\\dots,n_W$, and $k = 1,\\dots,n_A$. Here $\\mu$ is the overall mean concentration, $S_i$ is the random effect for subject $i$ (between-subject component), $W_{ij}$ is the random effect for visit $j$ within subject $i$ (within-subject component), and $A_{ijk}$ is the residual analytical error (analytical component). Assume $S_i \\sim \\mathcal{N}(0,\\sigma_S^2)$, $W_{ij} \\sim \\mathcal{N}(0,\\sigma_W^2)$, and $A_{ijk} \\sim \\mathcal{N}(0,\\sigma_A^2)$, with all effects mutually independent.\n\nThe experiment used $n_S = 12$ subjects, $n_W = 3$ visits per subject, and $n_A = 2$ analytical replicates per sample, and produced the following balanced, one-way nested Analysis of Variance (ANOVA) sums of squares and degrees of freedom for each level:\n- Between subjects: sum of squares $SS_S = 814$ with degrees of freedom $df_S = 11$.\n- Between visits within subjects: sum of squares $SS_W = 336$ with degrees of freedom $df_W = 24$.\n- Between analytical replicates within visits: sum of squares $SS_A = 216$ with degrees of freedom $df_A = 36$.\n\nUsing only fundamental definitions of variance components in a balanced random-effects nested design and the properties of expected mean squares under normal, independent random effects, estimate the three variance components $\\sigma_A^2$ (analytical), $\\sigma_W^2$ (within-subject), and $\\sigma_S^2$ (between-subject). Then, compute the estimated total variance of a single replicate biomarker measurement, defined as $\\sigma_A^2 + \\sigma_W^2 + \\sigma_S^2$.\n\nExpress your final answer as the single numeric value of the total variance in $(\\text{ng/mL})^2$. Provide the exact value; do not round.", "solution": "The problem requires the estimation of variance components from a balanced, nested random-effects model using results from an Analysis of Variance (ANOVA). The model for a single observation is given as:\n$$\ny_{ijk} = \\mu + S_i + W_{ij} + A_{ijk}\n$$\nwhere $i = 1, \\dots, n_S$, $j = 1, \\dots, n_W$, and $k = 1, \\dots, n_A$. The terms are defined as:\n- $\\mu$: the overall mean concentration.\n- $S_i$: the random effect for subject $i$, with $S_i \\sim \\mathcal{N}(0, \\sigma_S^2)$. $\\sigma_S^2$ is the between-subject variance component.\n- $W_{ij}$: the random effect for visit $j$ within subject $i$, with $W_{ij} \\sim \\mathcal{N}(0, \\sigma_W^2)$. $\\sigma_W^2$ is the within-subject biological variance component.\n- $A_{ijk}$: the residual analytical error for replicate $k$ of the sample from visit $j$ of subject $i$, with $A_{ijk} \\sim \\mathcal{N}(0, \\sigma_A^2)$. $\\sigma_A^2$ is the analytical variance component.\nAll random effects are assumed to be mutually independent.\n\nThe problem provides the following data from the experiment and the corresponding ANOVA:\n- Number of subjects, $n_S = 12$.\n- Number of visits per subject, $n_W = 3$.\n- Number of analytical replicates per sample, $n_A = 2$.\n- Between-subjects sum of squares, $SS_S = 814$, with degrees of freedom, $df_S = 11$.\n- Within-subjects (between-visits) sum of squares, $SS_W = 336$, with degrees of freedom, $df_W = 24$.\n- Within-visits (between-replicates/analytical) sum of squares, $SS_A = 216$, with degrees of freedom, $df_A = 36$.\n\nThe method of moments is used to estimate the variance components by equating the observed mean squares ($MS$) from the ANOVA table to their theoretical expected values ($E[MS]$).\n\nFirst, we calculate the mean squares for each source of variation:\n- Analytical Mean Square ($MS_A$): This corresponds to the variation between replicates within each visit and subject.\n$$\nMS_A = \\frac{SS_A}{df_A} = \\frac{216}{36} = 6\n$$\n- Within-Subject Mean Square ($MS_W$): This corresponds to the variation between visits within each subject.\n$$\nMS_W = \\frac{SS_W}{df_W} = \\frac{336}{24} = 14\n$$\n- Between-Subject Mean Square ($MS_S$): This corresponds to the variation between subjects.\n$$\nMS_S = \\frac{SS_S}{df_S} = \\frac{814}{11} = 74\n$$\n\nNext, we use the standard formulas for the expected mean squares in a balanced, three-level nested random-effects model:\n$$\nE(MS_A) = \\sigma_A^2\n$$\n$$\nE(MS_W) = \\sigma_A^2 + n_A \\sigma_W^2\n$$\n$$\nE(MS_S) = \\sigma_A^2 + n_A \\sigma_W^2 + n_A n_W \\sigma_S^2\n$$\n\nBy substituting the calculated mean squares in place of their expected values, we obtain a system of equations to solve for the estimates of the variance components, denoted as $\\hat{\\sigma}_A^2$, $\\hat{\\sigma}_W^2$, and $\\hat{\\sigma}_S^2$.\n\n1.  Estimate the analytical variance, $\\hat{\\sigma}_A^2$:\n    $$\n    MS_A = \\hat{\\sigma}_A^2\n    $$\n    $$\n    \\hat{\\sigma}_A^2 = 6\n    $$\n\n2.  Estimate the within-subject variance, $\\hat{\\sigma}_W^2$:\n    $$\n    MS_W = \\hat{\\sigma}_A^2 + n_A \\hat{\\sigma}_W^2\n    $$\n    We substitute the known values for $MS_W$, $\\hat{\\sigma}_A^2$, and $n_A$:\n    $$\n    14 = 6 + 2 \\hat{\\sigma}_W^2\n    $$\n    Solving for $\\hat{\\sigma}_W^2$:\n    $$\n    2 \\hat{\\sigma}_W^2 = 14 - 6 = 8\n    $$\n    $$\n    \\hat{\\sigma}_W^2 = \\frac{8}{2} = 4\n    $$\n\n3.  Estimate the between-subject variance, $\\hat{\\sigma}_S^2$:\n    $$\n    MS_S = \\hat{\\sigma}_A^2 + n_A \\hat{\\sigma}_W^2 + n_A n_W \\hat{\\sigma}_S^2\n    $$\n    We can simplify this by noting that $MS_W = \\hat{\\sigma}_A^2 + n_A \\hat{\\sigma}_W^2$. Substituting this into the equation for $MS_S$:\n    $$\n    MS_S = MS_W + n_A n_W \\hat{\\sigma}_S^2\n    $$\n    Now, substitute the known values for $MS_S$, $MS_W$, $n_A$, and $n_W$:\n    $$\n    74 = 14 + (2)(3) \\hat{\\sigma}_S^2\n    $$\n    $$\n    74 = 14 + 6 \\hat{\\sigma}_S^2\n    $$\n    Solving for $\\hat{\\sigma}_S^2$:\n    $$\n    6 \\hat{\\sigma}_S^2 = 74 - 14 = 60\n    $$\n    $$\n    \\hat{\\sigma}_S^2 = \\frac{60}{6} = 10\n    $$\n\nThe estimated variance components are:\n- Analytical variance, $\\hat{\\sigma}_A^2 = 6 \\ (\\text{ng/mL})^2$\n- Within-subject variance, $\\hat{\\sigma}_W^2 = 4 \\ (\\text{ng/mL})^2$\n- Between-subject variance, $\\hat{\\sigma}_S^2 = 10 \\ (\\text{ng/mL})^2$\n\nThe problem asks for the estimated total variance of a single replicate biomarker measurement. According to the model, a single measurement $y_{ijk}$ is the sum of the mean and the three independent random effects. The total variance of a single observation is the sum of the variances of these random components:\n$$\n\\text{Var}(y_{ijk}) = \\text{Var}(\\mu + S_i + W_{ij} + A_{ijk}) = \\text{Var}(S_i) + \\text{Var}(W_{ij}) + \\text{Var}(A_{ijk}) = \\sigma_S^2 + \\sigma_W^2 + \\sigma_A^2\n$$\nThe estimated total variance, $\\hat{\\sigma}_{\\text{total}}^2$, is the sum of the estimated variance components:\n$$\n\\hat{\\sigma}_{\\text{total}}^2 = \\hat{\\sigma}_S^2 + \\hat{\\sigma}_W^2 + \\hat{\\sigma}_A^2\n$$\nSubstituting the calculated values:\n$$\n\\hat{\\sigma}_{\\text{total}}^2 = 10 + 4 + 6 = 20\n$$\nThe total variance is $20 \\ (\\text{ng/mL})^2$.", "answer": "$$\n\\boxed{20}\n$$", "id": "4525758"}, {"introduction": "Understanding a biomarker's sources of variability is crucial, but the ultimate goal is to apply this knowledge to clinical interpretation. The Index of Individuality provides a powerful metric for deciding whether a common population-based reference range is useful for monitoring an individual, or if changes must be judged against the person's own baseline. In this practice, you will use variance components to calculate this index and make a critical judgment about the biomarker's clinical utility [@problem_id:4525795].", "problem": "A pharmacology team is evaluating a candidate biomarker for drug response monitoring in a Phase I study. To judge the suitability of population-based reference intervals, they plan to quantify the biomarkerâ€™s individuality using the index of individuality. The biomarker concentration was measured in $n$ healthy volunteers across multiple visits, with duplicate assay runs per sample. A nested random-effects analysis of variance (ANOVA, analysis of variance) provided the following variance component estimates and the grand mean concentration:\n- Between-subject biological variance $s_{G}^{2} = 625$ (in concentration units squared).\n- Within-subject biological variance $s_{I}^{2} = 144$ (in concentration units squared).\n- Analytical variance $s_{A}^{2} = 49$ (in concentration units squared).\n- Grand mean $\\mu = 200$ (in concentration units).\n\nUse the following fundamental definitions and facts:\n- The coefficient of variation (CV, coefficient of variation) for a source of variation with standard deviation $\\sigma$ and mean $\\mu$ is $\\mathrm{CV} = \\sigma / \\mu$.\n- Independent sources of variation have variances that add linearly; when expressed as coefficients of variation, their contributions add in quadrature.\n- The index of individuality quantifies how large the within-subject dispersion is relative to the between-subject dispersion when interpreting individual measurements against population-based reference intervals.\n- As a widely accepted interpretive guide, population-based reference intervals are generally of limited value when the index of individuality is less than $0.6$, useful when it exceeds $1.4$, and intermediate otherwise.\n\nCompute the analytically corrected index of individuality for this biomarker based on the provided variance components and grand mean. Express your final numeric answer as a pure number without units, and round your answer to four significant figures.", "solution": "The problem requires the computation of the analytically corrected index of individuality for a candidate biomarker based on provided variance components from a nested random-effects analysis of variance (ANOVA).\n\nFirst, a validation of the problem statement is performed.\n\n**Step 1: Extract Givens**\n- Between-subject biological variance: $s_{G}^{2} = 625$\n- Within-subject biological variance: $s_{I}^{2} = 144$\n- Analytical variance: $s_{A}^{2} = 49$\n- Grand mean: $\\mu = 200$\n- Definition of Coefficient of Variation (CV): $\\mathrm{CV} = \\sigma / \\mu$\n- Definition of Index of Individuality (II): A measure of the within-subject dispersion relative to the between-subject dispersion.\n- Interpretive guide for II: $< 0.6$ (limited utility), $> 1.4$ (useful), intermediate otherwise.\n\n**Step 2: Validate Using Extracted Givens**\nThe problem is scientifically grounded, employing standard concepts from biostatistics and clinical pharmacology, such as variance component analysis and the index of individuality, which are fundamental to biomarker validation. The problem is well-posed, providing all necessary numerical data and definitions for a unique solution. The language is objective and precise. The term \"analytically corrected\" is interpreted to mean that the variance components have been appropriately separated by the ANOVA model, allowing for the correct construction of the index, which is a standard assumption in such analyses. The problem is self-contained and free of contradictions or scientifically unsound premises.\n\n**Step 3: Verdict and Action**\nThe problem is deemed valid. A solution will be derived.\n\nThe index of individuality, denoted as $\\text{II}$, is a dimensionless ratio that compares the magnitude of total within-subject variability to the between-subject variability.\n\nThe total within-subject variability arises from two independent sources: the true biological fluctuations within an individual over time (intra-individual) and the error associated with the measurement process (analytical). The variances of independent sources are additive. Therefore, the total within-subject variance, $\\sigma_{\\text{within}}^{2}$, is the sum of the within-subject biological variance, $s_{I}^{2}$, and the analytical variance, $s_{A}^{2}$.\n$$\n\\sigma_{\\text{within}}^{2} = s_{I}^{2} + s_{A}^{2}\n$$\nThe corresponding total within-subject standard deviation is:\n$$\n\\sigma_{\\text{within}} = \\sqrt{s_{I}^{2} + s_{A}^{2}}\n$$\nThe between-subject variability reflects the dispersion of individual homeostatic set points across the population. The between-subject variance is given as $s_{G}^{2}$. The corresponding between-subject standard deviation, $\\sigma_{\\text{between}}$, is:\n$$\n\\sigma_{\\text{between}} = \\sqrt{s_{G}^{2}} = s_{G}\n$$\nThe index of individuality ($\\text{II}$) is defined as the ratio of these two standard deviations:\n$$\n\\text{II} = \\frac{\\sigma_{\\text{within}}}{\\sigma_{\\text{between}}} = \\frac{\\sqrt{s_{I}^{2} + s_{A}^{2}}}{s_{G}}\n$$\nWe are given the following variance components:\n- $s_{G}^{2} = 625$\n- $s_{I}^{2} = 144$\n- $s_{A}^{2} = 49$\n\nFirst, we calculate the standard deviations.\nThe between-subject standard deviation is:\n$$\ns_{G} = \\sqrt{625} = 25\n$$\nThe total within-subject variance is:\n$$\n\\sigma_{\\text{within}}^{2} = 144 + 49 = 193\n$$\nThe total within-subject standard deviation is:\n$$\n\\sigma_{\\text{within}} = \\sqrt{193}\n$$\nNow, we can compute the index of individuality:\n$$\n\\text{II} = \\frac{\\sqrt{193}}{25}\n$$\nTo obtain the numerical value, we evaluate the expression:\n$$\n\\text{II} \\approx \\frac{13.89244399}{25} \\approx 0.55569776\n$$\nThe problem requires the answer to be rounded to four significant figures.\n$$\n\\text{II} \\approx 0.5557\n$$\nAs a check, we can perform the calculation using coefficients of variation (CV).\nThe between-subject coefficient of variation, $\\mathrm{CV}_{G}$, is:\n$$\n\\mathrm{CV}_{G} = \\frac{s_{G}}{\\mu} = \\frac{25}{200} = 0.125\n$$\nThe within-subject biological coefficient of variation, $\\mathrm{CV}_{I}$, is:\n$$\n\\mathrm{CV}_{I} = \\frac{s_{I}}{\\mu} = \\frac{\\sqrt{144}}{200} = \\frac{12}{200} = 0.06\n$$\nThe analytical coefficient of variation, $\\mathrm{CV}_{A}$, is:\n$$\n\\mathrm{CV}_{A} = \\frac{s_{A}}{\\mu} = \\frac{\\sqrt{49}}{200} = \\frac{7}{200} = 0.035\n$$\nThe total within-subject coefficient of variation, $\\mathrm{CV}_{\\text{within}}$, is obtained by adding the component CVs in quadrature:\n$$\n\\mathrm{CV}_{\\text{within}} = \\sqrt{\\mathrm{CV}_{I}^{2} + \\mathrm{CV}_{A}^{2}} = \\sqrt{(0.06)^{2} + (0.035)^{2}} = \\sqrt{0.0036 + 0.001225} = \\sqrt{0.004825}\n$$\nThe index of individuality is the ratio of the total within-subject CV to the between-subject CV:\n$$\n\\text{II} = \\frac{\\mathrm{CV}_{\\text{within}}}{\\mathrm{CV}_{G}} = \\frac{\\sqrt{0.004825}}{0.125} \\approx \\frac{0.06946222}{0.125} \\approx 0.55569776\n$$\nThis confirms the previous calculation. Rounding to four significant figures gives $0.5557$. Based on the provided interpretive guide, an index of individuality of approximately $0.5557$ is less than $0.6$, suggesting that population-based reference intervals are of limited value for this particular biomarker.", "answer": "$$\\boxed{0.5557}$$", "id": "4525795"}]}